O'Rourke N - Search Results

1

Lung cancer treatment waiting times and tumour growth.

O'Rourke N, Edwards R. O'Rourke N, et al. Clin Oncol (R Coll Radiol). 2000;12(3):141-4. doi: 10.1053/clon.2000.9139. Clin Oncol (R Coll Radiol). 2000. PMID: 10942328

2

Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? A review of guidelines and evidence.

O'Rourke N, Macbeth F. O'Rourke N, et al. Clin Oncol (R Coll Radiol). 2010 Jun;22(5):347-55. doi: 10.1016/j.clon.2010.03.007. Epub 2010 Apr 27. Clin Oncol (R Coll Radiol). 2010. PMID: 20427167 Review.

3

Tumour induced hypercalcaemia: a case for active treatment.

O'Rourke NP, McCloskey EV, Kanis JA. O'Rourke NP, et al. Clin Oncol (R Coll Radiol). 1994;6(3):172-6. doi: 10.1016/s0936-6555(94)80057-x. Clin Oncol (R Coll Radiol). 1994. PMID: 8086352

4

Concurrent chemoradiotherapy in non-small cell lung cancer.

O'Rourke N, Roqué I Figuls M, Farré Bernadó N, Macbeth F. O'Rourke N, et al. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD002140. doi: 10.1002/14651858.CD002140.pub3. Cochrane Database Syst Rev. 2010. PMID: 20556756 Review.

5

Health-related quality of life in patients on radiotherapy waiting lists.

Hughes V, O'Rourke N. Hughes V, et al. Clin Oncol (R Coll Radiol). 2002 Aug;14(4):330. doi: 10.1053/clon.2002.0083. Clin Oncol (R Coll Radiol). 2002. PMID: 12206648 No abstract available.

6

The National Lung Matrix Trial of personalized therapy in lung cancer.

Middleton G, Fletcher P, Popat S, Savage J, Summers Y, Greystoke A, Gilligan D, Cave J, O'Rourke N, Brewster A, Toy E, Spicer J, Jain P, Dangoor A, Mackean M, Forster M, Farley A, Wherton D, Mehmi M, Sharpe R, Mills TC, Cerone MA, Yap TA, Watkins TBK, Lim E, Swanton C, Billingham L. Middleton G, et al. Nature. 2020 Jul;583(7818):807-812. doi: 10.1038/s41586-020-2481-8. Epub 2020 Jul 15. Nature. 2020. PMID: 32669708 Free PMC article. Clinical Trial.

7

ADVANCE-1: An adapted collaborative benchmarking approach in centre-based lung cancer care.

McCann B, Muhr R, O'Rourke N, Milroy R, Kollmeier J, Misch D, van der Horst J, Morrison D, Bauer T, Massalski O, Blum TG. McCann B, et al. Lung Cancer. 2021 Jan;151:44-52. doi: 10.1016/j.lungcan.2020.11.019. Epub 2020 Nov 26. Lung Cancer. 2021. PMID: 33307417

8

Concurrent chemoradiotherapy in non-small cell lung cancer.

Rowell NP, O'rourke NP. Rowell NP, et al. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002140. doi: 10.1002/14651858.CD002140.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495029 Updated. Review.

9

Toxicity of hypofractionated accelerated radiotherapy concurrent with chemotherapy for non-small cell carcinoma of the lung.

Carruthers R, O'Rourke N, Mohammed N, Hicks J, Brisbane I. Carruthers R, et al. Clin Oncol (R Coll Radiol). 2011 Oct;23(8):561-2. doi: 10.1016/j.clon.2011.05.006. Epub 2011 Jun 14. Clin Oncol (R Coll Radiol). 2011. PMID: 21676603 Clinical Trial. No abstract available.

10

SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status.

Maguire J, Khan I, McMenemin R, O'Rourke N, McNee S, Kelly V, Peedell C, Snee M. Maguire J, et al. Eur J Cancer. 2014 Nov;50(17):2939-49. doi: 10.1016/j.ejca.2014.07.009. Epub 2014 Oct 7. Eur J Cancer. 2014. PMID: 25304298 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

285 results

Search Page